A new study has found that for some patients with treatment-resistant prostate cancer, a new treatment can “block" the messages cancer uses to “hijack" white blood cells.
New prostate cancer treatment may eliminate recurrent tumorsPatricia Anstett
According to Dr. Raman, "This image-guided therapy maximizes our ability to killcancer cellswhile minimizingcollateral damageto the prostate to achieve the ultimate trifecta inprostate cancer treatment: full local cancer control while maintaining urinary continence and potency. The latter are the complic...
Even though T cell-based checkpoint immunotherapy has revolutionized cancer treatment, the poor immunogenic response of T cell-based immune checkpoint strategies against CTLA-4 and PD-L1 triggers the discovery of novel ‘checkpoints’ on other immune cells, particularly natural killer (NK) cells, wh...
"This award is really important because it means that we're doing something clinically relevant for all prostatecancer patients," he said. "Given the current state of how people are being diverted to whatever treatment, if we can reduce the 75 per cent false-positivity rate, I think it can...
Editorial Comment on: New treatment approaches for prostate cancer based on peptide analogues Aristotelis Bamias , Meletios A. Dimopoulos Show moreShow less Choose an option to locate/access this article: Check if you have access through your login credentials or your institutionCheck access Purchas...
doi:10.1038/nrurol.2013.232Grivas, Petros D.Keller, Evan T.Nature Reviews UrologyPetros D.Grivas, Evan T.Keller. (2013) Prostate cancer: Radium-223: a new treatment option for bone-metastatic CRPC. Nature Reviews Urology 10 , 630-631 /...
The UK ProtecT (Prostate testing for cancer and Treatment) Study Collaborators, The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, … Douglas F Easton Show authors Nature Genetics volume 45, pages 385–391 (2013)Cite this artic...
000 die from prostate cancer (GLOBOCAN). There was over four times the incidence of prostate cancer in 2017 as in the 1950s, but at the same time, the treatments have been improving, so many more live longer, and die with, rather than of, prostate cancer. Nevertheless, more effective ...
Many patients with prostate cancer are treated with drugs that lower or block hormones that fuel tumor growth. While the drugs are effective for a time, most patients eventually develop resistance to these therapies.